Michaud, Kaleb <br/><br/>
Outcomes and costs of incorporating a multibiomarker disease activity test in the management of patients with rheumatoid arthritis.  [electronic resource] 

 -  Rheumatology (Oxford, England)  Sep 2015 
 - 1640-9 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1462-0332 
<br/><br/><label>Standard No.: </label>10.1093/rheumatology/kev023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--blood<br/>Biomarkers--blood<br/>Cost-Benefit Analysis<br/>Decision Support Techniques<br/>Disability Evaluation<br/>Disease Management<br/>Health Care Costs<br/>Hematologic Tests--economics<br/>Humans<br/>Outcome Assessment, Health Care<br/>Prognosis<br/>Quality-Adjusted Life Years<br/>Sensitivity and Specificity<br/>Severity of Illness Index